Your browser doesn't support javascript.
loading
Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model.
Mas, Christophe; Boda, Bernadett; CaulFuty, Mireille; Huang, Song; Wiszniewski, Ludovic; Constant, Samuel.
Affiliation
  • Mas C; OncoTheis Sàrl, 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland. Electronic address: christophe.mas@oncotheis.com.
  • Boda B; OncoTheis Sàrl, 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland.
  • CaulFuty M; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Huang S; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Wiszniewski L; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
  • Constant S; OncoTheis Sàrl, 14 chemin des aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland; Epithelix Sàrl, Plan-les-Ouates, Switzerland.
J Biotechnol ; 205: 111-9, 2015 Jul 10.
Article in En | MEDLINE | ID: mdl-25615947

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Pyrimidinones / Benzimidazoles / Drug Screening Assays, Antitumor / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Biotechnol Journal subject: BIOTECNOLOGIA Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Pyrimidinones / Benzimidazoles / Drug Screening Assays, Antitumor / Protein Kinase Inhibitors / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Biotechnol Journal subject: BIOTECNOLOGIA Year: 2015 Type: Article